These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Preliminary results of dose intensive pre-irradiation chemotherapy in patients older than 10 years of age with high risk medulloblastoma and supratentorial primitive neuroectodermal tumors. Dhodapkar K; Dunkel IJ; Gardner S; Sapp M; Thoron L; Finlay J Med Pediatr Oncol; 2002 Jan; 38(1):47-8. PubMed ID: 11835236 [No Abstract] [Full Text] [Related]
26. Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours. A report from the Australia and New Zealand Childhood Cancer Study Group (ANZCCSG). White L; Johnston H; Jones R; Mameghan H; Nayanar V; McWhirter W; Kellie S; Waters K; Toogood I Cancer Chemother Pharmacol; 1993; 32(5):403-6. PubMed ID: 8339393 [TBL] [Abstract][Full Text] [Related]
27. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor. Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462 [TBL] [Abstract][Full Text] [Related]
28. [Post-operative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of German prospective randomised trial HIT'91]. Noël G; Mazeron JJ Cancer Radiother; 2001 Apr; 5(2):197-8. PubMed ID: 11355586 [No Abstract] [Full Text] [Related]
29. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy. Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826 [TBL] [Abstract][Full Text] [Related]
32. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas. Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528 [TBL] [Abstract][Full Text] [Related]
33. Current treatment approaches for infants with malignant central nervous system tumors. Lafay-Cousin L; Strother D Oncologist; 2009 Apr; 14(4):433-44. PubMed ID: 19342475 [TBL] [Abstract][Full Text] [Related]
35. The treatment of malignant scala posterior tumors in children: II. Preliminary result of the pre- and postoperative adjuvant chemotherapy of scala posterior tumors. Schuler D; Somló P; Koós R; Kálmánchey R; Paraicz E Med Pediatr Oncol; 1993; 21(4):274-9. PubMed ID: 8469223 [TBL] [Abstract][Full Text] [Related]
36. Supratentorial ependymoma: disease control, complications, and functional outcomes after irradiation. Landau E; Boop FA; Conklin HM; Wu S; Xiong X; Merchant TE Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):e193-9. PubMed ID: 23245280 [TBL] [Abstract][Full Text] [Related]
37. Supratentorial ependymomas of the first two decades of life. Long-term follow-up of 20 cases (including two subependymomas). Palma L; Celli P; Cantore G Neurosurgery; 1993 Feb; 32(2):169-75. PubMed ID: 8437653 [TBL] [Abstract][Full Text] [Related]
39. Long-term clinical effects of radiation therapy for primitive gliomas and medulloblastomas: a role for radiosurgery. Inoue HK; Nakamura M; Ono N; Kawashima Y; Hirato M; Ohye C Stereotact Funct Neurosurg; 1993; 61 Suppl 1():51-8. PubMed ID: 8115756 [TBL] [Abstract][Full Text] [Related]